BFC Planning’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.41K Buy
+70
New +$1.26K ﹤0.01% 3096

Other funds holding AMRX

BFC Planning's AMRX Position: Q3 2026 in Review

BFC Planning opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 70 shares worth $1.41K. The stake represents ﹤0.01% of the portfolio and ranks #3096 among its holdings.

264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • BFC Planning held 70 shares of Amneal Pharmaceuticals worth $1.41K as of Q3 2026.
  • Amneal Pharmaceuticals was a new BFC Planning position in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3096 holding.
  • 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.